Aarey Drugs Promoters Convert Warrants to Shares

Aarey Drugs & Pharmaceuticals Ltd has filed a disclosure under SEBI PIT Regulations, 2015, detailing the conversion of warrants into equity shares by its promoters and promoter group. The transactions, effective from September 30, 2026, involved the allotment of equity shares pursuant to the conversion of warrants. Key individuals like Bina Rajesh Ghatalia, Mihir Rajesh Ghatalia, Nimit Rajesh Ghatalia, Mira Mihir Ghatalia, Ekta Nimit Ghatalia, and Mihir Rajesh Ghatalia (HUF) saw their shareholding change post-allotment. For instance, Bina Rajesh Ghatalia's holding increased from 14.12% to 14.13% after acquiring 500,000 equity shares valued at ₹23,925,000. Similarly, Mihir Rajesh Ghatalia's equity shareholding changed from 10.00% to 9.98% after acquiring 345,000 equity shares worth ₹16,508,250. The total value of warrants converted across all listed individuals amounts to ₹100,223,250.